Pfizer, BioNTech seek to extend Covid-19 vaccine use to adolescents in EU
The submission is based on positive data from a late-stage clinical trial.
Pfizer Inc and partner BioNTech SE said on Friday they had applied to the European health regulator to extend the marketing authorization for their coronavirus vaccine for use in adolescents aged 12 to 15.
The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
US Centers for Disease Control and Prevention director Rochelle Walensky told ABC News earlier this month that she expected the vaccine to be authorized for 12- to 15-year-olds by mid-May.
However, the number of doctors in the NHS is at a record high,... READ MORE
The fireworks will take place over three nights. READ MORE
More than 44.6 million Covid-19 tests have been carried out in the... READ MORE
The Indian variant of the virus has reached at least 17 countries. READ MORE
Toll charges will resume once the holiday period is over. READ MORE
Whoever sees the moon with the naked eye or through binoculars has... READ MORE
He had been on the run from the authorities for over eight years. READ MORE
Covid-19 assessment centres in Al Badaa, Al Khawaneej and Dubai... READ MORE